Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Outbreak of invasive Streptococcus pneumoniae among an inner-city population in Victoria, British Columbia, 2016-2017.

McKee G, Choi A, Madill C, Marriott J, Kibsey P, Hoyano D.

Can Commun Dis Rep. 2018 Dec 6;44(12):317-322. doi: 10.14745/ccdr.v44i12a02. eCollection 2018 Dec 6.

2.

Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010-16.

Boyd DA, Mataseje LF, Pelude L, Mitchell R, Bryce E, Roscoe D, Embree J, Katz K, Kibsey P, Lavallee C, Simor AE, Taylor G, Turgeon N, Langley JM, Amaratunga K, Mulvey MR; Canadian Nosocomial Infection Surveillance Program .

J Antimicrob Chemother. 2019 Feb 1;74(2):315-320. doi: 10.1093/jac/dky416.

PMID:
30312401
3.

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015).

Katz KC, Golding GR, Choi KB, Pelude L, Amaratunga KR, Taljaard M, Alexandre S, Collet JC, Davis I, Du T, Evans GA, Frenette C, Gravel D, Hota S, Kibsey P, Langley JM, Lee BE, Lemieux C, Longtin Y, Mertz D, Mieusement LMD, Minion J, Moore DL, Mulvey MR, Richardson S, Science M, Simor AE, Stagg P, Suh KN, Taylor G, Wong A, Thampi N; Canadian Nosocomial Infection Surveillance Program.

CMAJ. 2018 Jun 25;190(25):E758-E765. doi: 10.1503/cmaj.180013.

4.

Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.

Mataseje LF, Abdesselam K, Vachon J, Mitchel R, Bryce E, Roscoe D, Boyd DA, Embree J, Katz K, Kibsey P, Simor AE, Taylor G, Turgeon N, Langley J, Gravel D, Amaratunga K, Mulvey MR.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6787-6794. doi: 10.1128/AAC.01359-16. Print 2016 Nov.

5.

Characterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region.

Jassem AN, Prystajecky N, Marra F, Kibsey P, Tan K, Umlandt P, Janz L, Champagne S, Gamage B, Golding GR, Mulvey MR, Henry B, Hoang LM.

Can J Infect Dis Med Microbiol. 2016;2016:8207418. doi: 10.1155/2016/8207418. Epub 2016 Mar 29.

6.

New approaches to infection prevention and control: implementing a risk-based model regionally.

Wale M, Kibsey P, Young L, Dobbyn B, Archer J.

Int J Qual Health Care. 2016 Jun;28(3):405-11. doi: 10.1093/intqhc/mzw041. Epub 2016 May 18.

PMID:
27194074
7.

Reproducible elimination of Clostridium difficile spores using a clinical area washer disinfector in 3 different health care sites.

MacDonald K, Bishop J, Dobbyn B, Kibsey P, Alfa MJ.

Am J Infect Control. 2016 Jul 1;44(7):e107-11. doi: 10.1016/j.ajic.2016.01.024. Epub 2016 Mar 31.

PMID:
27040564
8.

Epidemiologic and Genotypic Review of Carbapenemase-Producing Organisms in British Columbia, Canada, between 2008 and 2014.

Sekirov I, Croxen MA, Ng C, Azana R, Chang Y, Mataseje L, Boyd D, Mangat C, Mack B, Tadros M, Brodkin E, Kibsey P, Stefanovic A, Champagne S, Mulvey MR, Hoang LM.

J Clin Microbiol. 2016 Feb;54(2):317-27. doi: 10.1128/JCM.02289-15. Epub 2015 Nov 25.

9.

Tatumella saanichensis sp. nov., isolated from a cystic fibrosis patient.

Tracz DM, Gilmour MW, Mabon P, Beniac DR, Hoang L, Kibsey P, Van Domselaar G, Tabor H, Westmacott GR, Corbett CR, Bernard KA.

Int J Syst Evol Microbiol. 2015 Jun;65(Pt 6):1959-66. doi: 10.1099/ijs.0.000207. Epub 2015 Mar 25.

PMID:
25807976
10.

Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia.

Phillips P, Galanis E, MacDougall L, Chong MY, Balshaw R, Cook VJ, Bowie W, Steiner T, Hoang L, Morshed M, Ghesquiere W, Forrest DM, Roscoe D, Doyle P, Kibsey PC, Connolly T, Mirzanejad Y, Thompson D; British Columbia Cryptococcus gattii Study Group.

Clin Infect Dis. 2015 May 1;60(9):1368-76. doi: 10.1093/cid/civ041. Epub 2015 Jan 28.

PMID:
25632012
11.

Complete Sequence of Four Multidrug-Resistant MOBQ1 Plasmids Harboring blaGES-5 Isolated from Escherichia coli and Serratia marcescens Persisting in a Hospital in Canada.

Boyd D, Taylor G, Fuller J, Bryce E, Embree J, Gravel D, Katz K, Kibsey P, Kuhn M, Langley J, Mataseje L, Mitchell R, Roscoe D, Simor A, Thomas E, Turgeon N, Mulvey M; Canadian Nosocomial Infection Surveillance Program.

Microb Drug Resist. 2015 Jun;21(3):253-60. doi: 10.1089/mdr.2014.0205. Epub 2014 Dec 29.

PMID:
25545311
12.

Proteomic analysis of a NAP1 Clostridium difficile clinical isolate resistant to metronidazole.

Chong PM, Lynch T, McCorrister S, Kibsey P, Miller M, Gravel D, Westmacott GR, Mulvey MR; Canadian Nosocomial Infection Surveillance Program (CNISP).

PLoS One. 2014 Jan 6;9(1):e82622. doi: 10.1371/journal.pone.0082622. eCollection 2014.

13.

Complete sequences of a novel blaNDM-1-harbouring plasmid from Providencia rettgeri and an FII-type plasmid from Klebsiella pneumoniae identified in Canada.

Mataseje LF, Boyd DA, Lefebvre B, Bryce E, Embree J, Gravel D, Katz K, Kibsey P, Kuhn M, Langley J, Mitchell R, Roscoe D, Simor A, Taylor G, Thomas E, Turgeon N, Mulvey MR; Canadian Nosocomial Infection Surveillance Program.

J Antimicrob Chemother. 2014 Mar;69(3):637-42. doi: 10.1093/jac/dkt445. Epub 2013 Nov 24.

PMID:
24275114
14.

Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate.

Lynch T, Chong P, Zhang J, Hizon R, Du T, Graham MR, Beniac DR, Booth TF, Kibsey P, Miller M, Gravel D, Mulvey MR; Canadian Nosocomial Infection Surveillance Program (CNISP).

PLoS One. 2013;8(1):e53757. doi: 10.1371/journal.pone.0053757. Epub 2013 Jan 17.

15.

Population-based laboratory assessment of the burden of community-onset bloodstream infection in Victoria, Canada.

Laupland KB, Kibsey PC, Gregson DB, Galbraith JC.

Epidemiol Infect. 2013 Jan;141(1):174-80. doi: 10.1017/S0950268812000428. Epub 2012 Mar 15.

PMID:
22417845
16.

Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP).

Mataseje LF, Bryce E, Roscoe D, Boyd DA, Embree J, Gravel D, Katz K, Kibsey P, Kuhn M, Mounchili A, Simor A, Taylor G, Thomas E, Turgeon N, Mulvey MR; Canadian Nosocomial Infection Surveillance Program.

J Antimicrob Chemother. 2012 Jun;67(6):1359-67. doi: 10.1093/jac/dks046. Epub 2012 Mar 7.

PMID:
22398651
17.

Characteristics of an Acanthamoeba keratitis outbreak in British Columbia between 2003 and 2007.

Fraser MN, Wong Q, Shah L, Holland SP, Morshed M, Isaac-Renton J, Chong M, Kibsey P, Patrick DM.

Ophthalmology. 2012 Jun;119(6):1120-5. doi: 10.1016/j.ophtha.2011.12.041. Epub 2012 Feb 23.

PMID:
22365067
18.

Community-onset bloodstream infection during the 'after hours' is not associated with an increased risk for death.

Laupland KB, Kibsey PC, Galbraith JC.

Can J Infect Dis Med Microbiol. 2012 Winter;23(4):170-2.

19.

Clinical presentation, diagnosis and management of Cryptococcus gattii cases: Lessons learned from British Columbia.

Galanis E, Hoang L, Kibsey P, Morshed M, Phillips P.

Can J Infect Dis Med Microbiol. 2009 Spring;20(1):23-8.

20.

High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.

Peirano G, Richardson D, Nigrin J, McGeer A, Loo V, Toye B, Alfa M, Pienaar C, Kibsey P, Pitout JD.

Antimicrob Agents Chemother. 2010 Mar;54(3):1327-30. doi: 10.1128/AAC.01338-09. Epub 2010 Jan 4.

21.

Rationale for and protocol of a multi-national population-based bacteremia surveillance collaborative.

Laupland KB, Schønheyder HC, Kennedy KJ, Lyytikäinen O, Valiquette L, Galbraith J, Collignon P, Church DL, Gregson DB, Kibsey P.

BMC Res Notes. 2009 Jul 22;2:146. doi: 10.1186/1756-0500-2-146.

22.

Tuberculous epididymitis following intravesical Bacillus Calmette-Guérin immunotherapy.

Hoag N, Pommerville PJ, Kibsey PC, Cavers DJ, Eddy RJ.

Can J Urol. 2009 Apr;16(2):4589-91.

PMID:
19364433
23.

Check Sample Abstracts.

Alter D, Grenache DG, Bosler DS, Karcher RE, Nichols J, Rajadhyaksha A, Camelo-Piragua S, Rauch C, Huddleston BJ, Frank EL, Sluss PM, Lewandrowski K, Eichhorn JH, Hall JE, Rahman SS, McPherson RA, Kiechle FL, Hammett-Stabler C, Pierce KA, Kloehn EA, Thomas PA, Walts AE, Madan R, Schlesinger K, Nawgiri R, Bhutani M, Kanber Y, Abati A, Atkins KA, Farrar R, Gopez EV, Jhala D, Griffin S, Jhala K, Jhala N, Bentz JS, Emerson L, Chadwick BE, Barroeta JE, Baloch ZW, Collins BT, Middleton OL, Davis GG, Haden-Pinneri K, Chu AY, Keylock JB, Ramoso R, Thoene CA, Stewart D, Pierce A, Barry M, Aljinovic N, Gardner DL, Barry M, Shields LB, Arnold J, Stewart D, Martin EL, Rakow RJ, Paddock C, Zaki SR, Prahlow JA, Stewart D, Shields LB, Rolf CM, Falzon AL, Hudacki R, Mazzella FM, Bethel M, Zarrin-Khameh N, Gresik MV, Gill R, Karlon W, Etzell J, Deftos M, Karlon WJ, Etzell JE, Wang E, Lu CM, Manion E, Rosenthal N, Wang E, Lu CM, Tang P, Petric M, Schade AE, Hall GS, Oethinger M, Hall G, Picton AR, Hoang L, Imperial MR, Kibsey P, Waites K, Duffy L, Hall GS, Salangsang JA, Bravo LT, Oethinger MD, Veras E, Silva E, Vicens J, Silva E, Keylock J, Hempel J, Rushing E, Posligua LE, Deavers MT, Nash JW, Basturk O, Perle MA, Greco A, Lee P, Maru D, Weydert JA, Stevens TM, Brownlee NA, Kemper AE, Williams HJ, Oliverio BJ, Al-Agha OM, Eskue KL, Newlands SD, Eltorky MA, Puri PK, Royer MC, Rush WL, Tavora F, Galvin JR, Franks TJ, Carter JE, Kahn AG, Lozada Muñoz LR, Houghton D, Land KJ, Nester T, Gildea J, Lefkowitz J, Lacount RA, Thompson HW, Refaai MA, Quillen K, Lopez AO, Goldfinger D, Muram T, Thompson H.

Am J Clin Pathol. 2009 Feb;131(2):286-299.

PMID:
19176368
24.

Cryptococcus gattii infections on Vancouver Island, British Columbia, Canada: emergence of a tropical fungus in a temperate environment.

Fyfe M, MacDougall L, Romney M, Starr M, Pearce M, Mak S, Mithani S, Kibsey P.

Can Commun Dis Rep. 2008 Jun;34(6):1-12. English, French.

25.

Tuberculosis of the bladder without previous renal infection.

Pommerville PJ, Zakus P, van der Westhuizen N, Kibsey PC.

Can J Urol. 2006 Apr;13(2):3044-6.

PMID:
16672117
26.

Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance determinant: characterization of the VanD5 operon.

Boyd DA, Kibsey P, Roscoe D, Mulvey MR.

J Antimicrob Chemother. 2004 Sep;54(3):680-3. Epub 2004 Aug 12.

PMID:
15308604
27.

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.

Davidson R, Cavalcanti R, Brunton JL, Bast DJ, de Azavedo JC, Kibsey P, Fleming C, Low DE.

N Engl J Med. 2002 Mar 7;346(10):747-50. No abstract available.

29.

Comparison of BACTEC Plus 26 and 27 media with and without fastidious organism supplement with conventional methods for culture of sterile body fluids.

Fuller DD, Davis TE, Kibsey PC, Rosmus L, Ayers LW, Ott M, Saubolle MA, Sewell DL.

J Clin Microbiol. 1994 Jun;32(6):1488-91.

30.

Containing cefoxitin costs through a program to curtail use in surgical prophylaxis.

Taylor G, Blondel-Hill E, Kibsey P, Friesen E, Tisdell R, Vaudry W.

Can J Infect Dis. 1993 Sep;4(5):275-8.

31.

Epidemiology of infections with Pseudomonas aeruginosa in burn patients: the role of hydrotherapy.

Tredget EE, Shankowsky HA, Joffe AM, Inkson TI, Volpel K, Paranchych W, Kibsey PC, Alton JD, Burke JF.

Clin Infect Dis. 1992 Dec;15(6):941-9.

PMID:
1457665
32.

Epidemiological studies of nosocomial infections with Pseudomonas aeruginosa using a DNA probe.

Joffe AM, Volpel K, Kibsey PC, Paranchych W.

Can J Infect Dis. 1992 Nov;3(6):299-306.

33.

The effects of ischemia and ischemia-reperfusion on bacterial translocation, lipid peroxidation, and gut histology: studies on hemorrhagic shock in pigs.

Morales J, Kibsey P, Thomas PD, Poznansky MJ, Hamilton SM.

J Trauma. 1992 Aug;33(2):221-6; discussion 226-7.

PMID:
1507285
34.

Laboratory and clinical evaluations of media for the primary isolation of Haemophilus species.

Rennie R, Gordon T, Yaschuk Y, Tomlin P, Kibsey P, Albritton W.

J Clin Microbiol. 1992 Aug;30(8):1917-21.

35.

Predominance of staphylococcal organisms in infections occurring in a burns intensive care unit.

Taylor GD, Kibsey P, Kirkland T, Burroughs E, Tredget E.

Burns. 1992 Aug;18(4):332-5.

PMID:
1418512
36.

Survey of Bacteroides fragilis group susceptibility patterns in Canada.

Bourgault AM, Lamothe F, Hoban DJ, Dalton MT, Kibsey PC, Harding G, Smith JA, Low DE, Gilbert H.

Antimicrob Agents Chemother. 1992 Feb;36(2):343-7.

37.

Hemorrhagic shock and bacterial translocation in a swine model.

Gelfand GA, Morales J, Jones RL, Kibsey P, Grace M, Hamilton SM.

J Trauma. 1991 Jun;31(6):867-74.

PMID:
2056553
38.

Relapsing Clostridium difficile colitis and Reiter's syndrome.

Hayward RS, Wensel RH, Kibsey P.

Am J Gastroenterol. 1990 Jun;85(6):752-6.

PMID:
2353699
39.

Comparison of a DNA probe with culture for detecting Chlamydia trachomatis directly from genital specimens.

Gratton CA, Lim-Fong R, Prasad E, Kibsey PC.

Mol Cell Probes. 1990 Feb;4(1):25-31.

PMID:
2179711
40.

In vitro activity of LY163892 against pathogens isolated from pediatric patients.

Wenman WM, Kibsey PC, Gratton CA, Knight VE.

Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):434-6. No abstract available.

PMID:
3137056
41.

Rotavirus infection in children with diarrhoea admitted to a general hospital in Metro Toronto.

Spence L, Singer O, Kibsey P, Fauvel M.

Can J Public Health. 1985 Jan-Feb;76(1):17-20. No abstract available.

PMID:
3978522
42.

Seroconversion rates with hepatitis B vaccine.

Strickler AC, Kibsey PC, Vellend H.

Ann Intern Med. 1984 Oct;101(4):564. No abstract available.

PMID:
6236728

Supplemental Content

Loading ...
Support Center